Process View
Any process that stops, prevents, or reduces the frequency, rate or extent of B cell activation.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of b cell activation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CD80 | CD80 molecule | 0.353 | ||
| THOC2 | THO complex 2 | 0.175 | ||
| IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.160 | ||
| THOC5 | THO complex 5 | 0.129 | ||
| CD86 | CD86 molecule | 0.079 | ||
| TNIP2 | TNFAIP3 interacting protein 2 | 0.079 | ||
| TFF1 | trefoil factor 1 | 0.070 | ||
| TNIP1 | TNFAIP3 interacting protein 1 | 0.067 | ||
| SLAMF1 | signaling lymphocytic activation molecule family member 1 | 0.064 | ||
| GRAP2 | GRB2-related adaptor protein 2 | 0.061 | ||
| IL10RA | interleukin 10 receptor, alpha | 0.060 | ||
| DDX39B | DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B | 0.060 | ||
| CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.056 | ||
| TP53BP1 | tumor protein p53 binding protein 1 | 0.052 | ||
| LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.045 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.044 | ||
| HDAC9 | histone deacetylase 9 | 0.042 | ||
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.037 | ||
| IL22RA2 | interleukin 22 receptor, alpha 2 | 0.034 | ||
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.033 | ||
| IL22RA1 | interleukin 22 receptor, alpha 1 | 0.031 | ||
| INPP5D | inositol polyphosphate-5-phosphatase, 145kDa | 0.028 | Mouse | |
| LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.027 | ||
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.027 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.027 | ||
| FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) | 0.025 | Mouse | |
| CASP7 | caspase 7, apoptosis-related cysteine peptidase | 0.019 | ||
| FRA10AC1 | fragile site, folic acid type, rare, fra(10)(q23.3) or fra(10)(q24.2) candidate 1 | 0.018 | ||
| THOC4 | THO complex 4 | 0.018 | ||
| PML | promyelocytic leukemia | 0.017 | ||
| MAPK12 | mitogen-activated protein kinase 12 | 0.016 | ||
| NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.015 | ||
| SH2D1A | SH2 domain containing 1A | 0.015 | ||
| RBCK1 | RanBP-type and C3HC4-type zinc finger containing 1 | 0.014 | ||
| IL4R | interleukin 4 receptor | 0.014 | ||
| TNF | tumor necrosis factor | 0.014 | ||
| ATMIN | ATM interactor | 0.013 | ||
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.012 | ||
| TERF1 | telomeric repeat binding factor (NIMA-interacting) 1 | 0.011 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.011 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.011 | ||
| FANCD2 | Fanconi anemia, complementation group D2 | 0.011 | ||
| CTLA4 | cytotoxic T-lymphocyte-associated protein 4 | 0.011 | ||
| DCLRE1C | DNA cross-link repair 1C | 0.010 |